165 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
the Amended and Restated Spyre 2023 Equity Incentive Plan. The Common Stock and the Series A Preferred Stock related to the Asset Acquisition were issued … options to purchase 2,734 shares of Common Stock from the Amended and Restated Spyre 2023 Equity Incentive Plan. On November 28, 2023, we changed our
424B3
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Prospectus supplement
4:06pm
compensation, excess benefit, profit-sharing, bonus, incentive, equity or equity-based, phantom equity, employment, consulting, severance, change … periodic report under the Exchange Act, other than pursuant to incentive awards issued under the Company’s incentive award plans, the issuance
8-K
EX-10.1
0bdmctp z6
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
POS AM
yvl6exe7yvf53wqtvp
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
POS AM
oz7se
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
S-8
fslhtvczg7
29 Feb 24
Registration of securities for employees
5:06pm
S-8
EX-5.1
jild1igk
29 Feb 24
Registration of securities for employees
5:06pm
S-8
4lirev9egvwmei
29 Feb 24
Registration of securities for employees
5:06pm